Official Publications PHAXIAM Therapeutics S.A.

Equities

End-of-day quote Euronext Paris Other stock markets 06:00:00 2024-05-26 pm EDT			5-day change	1st Jan Change
3.03 ^EUR	0.00%		-0.33%	-34.13%

Apr. 15	Phaxiam initiates trial in infective endocarditis	CF
Apr. 15	PHAXIAM Therapeutics Announces Enrolment of First Patient in the Phase 1 Study for the Treatment of Endocarditis Infections Caused by Staphylococcus Aureus	CI

Monthly statement on voting rights	23-08-30	CO
Monthly statement on voting rights	23-08-30	CO
Monthly statement on voting rights	23-07-30	CO
Monthly statement on voting rights	23-07-30	CO
Reverse split	23-07-30	CO
Various reports	23-07-30	CO
Threshold crossings	23-07-06	CO
Corporate officers' Statement -: xercise of Stock Options 4	23-07-04	CO
Corporate officers' Statement -: xercise of Stock Options 4	23-07-03	CO
Threshold crossings	23-07-02	CO
Corporate officers' Statement -: xercise of Stock Options 4	23-07-02	CO
Threshold crossings	23-06-29	CO
Monthly statement on voting rights	23-06-25	CO
Monthly statement on voting rights	23-06-25	CO
Change of company name	23-06-25	CO
Shareholders meeting voting results	23-06-22	CO
Shareholders meeting voting results	23-06-22	CO
Monthly statement on voting rights	23-05-30	CO
Monthly statement on voting rights	23-05-30	CO
General assembly meeting brochure	23-05-28	CO
General assembly meeting brochure	23-05-28	CO
Threshold crossings	23-05-23	CO
General assembly meeting brochure	23-05-16	CO
General assembly meeting brochure	23-05-16	CO
Corporate officers' Statement -: xercise of Stock Options 4	23-05-16	CO